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Tryptophyllins are a diverse family of amphibian peptides originally found in extracts of phyllomedusine frog skin by chemical
means.Their biological activities remain obscure. Here we describe the isolation and preliminary pharmacological characterization
of a novel type 2 tryptophyllin, named AcT-2, from the skin secretion of the red-eyed leaf frog, Agalychnis callidryas. The peptide
was initially identified during smooth muscle pharmacological screening of skin secretion HPLC fractions and the unique primary
structure—GMRPPWF-NH
2
—was established by both Edman degradation and electrosprayMS/MS fragmentation sequencing. A.
cDNA encoding the biosynthetic precursor of AcT-2 was successfully cloned from a skin secretion-derived cDNA library by means
of RACEPCRand this contained an open-reading frame consisting of 62 amino acid residueswith a singleAcT-2 encoding sequence
located towards the C-terminus. A synthetic replicate of AcT-2 was found to relax arterial smooth muscle (EC
50
= 5.1 nM) and to
contract rat urinary bladder smooth muscle (EC
50
= 9.3 𝜇M). The peptide could also inhibit the growth of the microorganisms,
Staphylococcus aureus, (MIC = 256mg/L) Escherichia coli (MIC = 512mg/L), and Candida albicans (128mg/L). AcT-2 is thus the
first amphibian skin tryptophyllin found to possess both myotropic and antimicrobial activities.
1. Introduction
Amphibians represent the most ancient group of terrestrial
vertebrates and are widely distributed globally, occurring
on all continents with the exception of Antarctica [1, 2].
Their continuing persistence in the biosphere can in part
be attributed to their highly developed and potent skin
secretions that act as a front-line defense against potential
predators and microbes [1, 2]. The biological potency of their
skins and associated secretions were recognized by many
ancient peoples who used such in shamanic rituals and as
medicines for diverse ailments [1, 2]. Some applications of
these secretions include those of bufonid toads as stimulants
in traditional Chinese medicine, those of tropical poison
frogs (dendrobatids) as arrow-tip poisons, and those of giant
monkey frogs (Phyllomedusa bicolor) in “hunting magic”—
a purging and sensory-enhancing ritual performed by some
South-American natives prior to hunting [3].
The unlocking of the molecular secrets of amphibian
defensive skin secretions was predominantly initiated by
two, twentieth-century pioneer pharmacological chemists—
Vittorio Erspamer (1909–1999) (endogenous peptides and
biogenic amines) and John Daly (1933–2008) (exogenous
alkaloids). Their combined efforts resulted in the unravelling
of the molecular structures and biological actions of several
thousands of such molecules representing many classes of
biochemical, studies on which have served to reveal many
novel regulatory systems and potential drug targets in mam-
malian systems [1–4].
The application of modern analytical technologies such
as molecular cloning, proteomics, and mass spectrometry
to the study of the molecular complexity of amphibian skin
secretions continues on where the pioneers left off with
ever-increasing numbers of unique molecules of diverse
functions being revealed [5]. One of the major goals of such
contemporary research is directed towards the identification
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of natural leads for therapeutic development or to identify
novel disease-related drug targets [6, 7].
The bioactive peptides represent one of the largest and
most functionally diverse groups of biochemicals identified
thus far from amphibian skin, and unlike the diet-acquired
alkaloids, these are of endogenous origin and are genetically
encoded [1–4]. While many individual peptides have been
isolated, they fall into two broad functional groupings—those
with pharmacological activity and those with antimicrobial
activity [1–4].
Tryptophyllins (TPHs) are a large and heterogenous
group of peptides that did not fall into either category when
first identified, as they were originally isolated from the
skin of the South-American leaf frog, Phyllomedusa rohdei,
through chemical means by nature of their positive Ehrlich’s
reaction—a color-producing chemical reaction for indoles
(tryptophan residues) [2]. All original TPHs possessed a
tryptophanyl residue at position 2 from the C-terminus and
prolyl residues at position 2 and/or 3 from the N-terminus
[2], although some TPHs more recently identified are devoid
of tryptophanyl residues [2]. Due to the increasing numbers
of TPHs being identified and their apparent structural het-
erogeneity, this peptide family has been divided into three
types—(1) tryptophyllin-1 (T-1) peptides: the N-terminal
doublet KP-, a tryptophanyl residue at position 5 and a prolyl
residue at position 7 from the N-terminus; are all highly
conserved in this group of peptides that typically possess 7-8
residues; (2) tryptophyllin-2 (T-2) peptides: these are variable
in length, contain 4 to 7 residues, and all contain an internal-
PW doublet; (3) tryptophyllin-3 (T-3) peptides: the most
conserved TPHs containing 13 residues with conservative
substitutions at positions 2, 5, 6, and 13 from the N-terminus.
The N-terminal pGlu-, -KP-, at positions 3 and 4 and
the 7–12 sequence, -PPPIYP-, are all completely conserved
[2, 8–10].
Although the structures of many TPHs have been known
for more than twenty-five years, their biological actions have
remained somewhat obscure until recently. In early reports,
TPHs were described as having some general metabolic
effects, such as stimulating liver protein synthesis and anti-
bodies raised to several of these peptides, produced positive
immunostaining in pituitary gonadotrophs [2]. In more
recent times, two tryptophyllins (PdT-1 and PdT-2) from
the skin secretion of the Mexican leaf frog, Pachymedusa
dacnicolor, were found to have potent pharmacological effects
on different rat smooth muscles [8, 9].
Here, we describe the identification, structural, and
functional characterization of a novel Type-2 tryptophyllin,
named AcT-2, from the skin secretion of the Central Amer-
ican red-eyed leaf frog, Agalychnis callidryas. This peptide
was first identified through pharmacological screening for
myotropic activity and was subsequently, in addition, found
to have a broad spectrum of antimicrobial activity, albeit
relatively low potency. Unusually, the peptide was found to
possess a higher potency against the yeast, Candida albicans,
than against the model Gram-positive and Gram-negative
bacteria employed.
2. Materials and Methods
2.1. Acquisition of Skin Secretions. Adult red-eyed tree frogs,
Agalychnis callidryas (𝑛 = 6), of the Costa Rican type, were
housed in a purpose-designed terrarium under a 12 h/12 h
light/dark cycle and were fed multivitamin-loaded crickets
three times per week. Skin secretions were obtained by trans-
dermal electrical stimulation (4ms pulse width, 50Hz, 6V)
in accordance with the method of Tyler et al. [11] following
a three-month settling-in period. The skin secretions were
washed from the skin using deionized water, snap frozen
in liquid nitrogen, lyophilized, and stored at −20∘C prior to
analyses.
2.2. Reverse Phase HPLC Fractionation of Lyophilized Skin
Secretion. Five milligrams of lyophilized skin secretion were
dissolved in 1mL of 0.05/99.95 (v/v) trifluoroacetic acid
(TFA)/water and clarified by centrifugation.The supernatant
was directly injected onto a CECIL reverse phase HPLC
system (Milton Technical Centre, Cambridge, UK) fittedwith
an analytical column (Phenomenex Jupiter C5; 300 A˚ pore
size; 250 × 4mm). The linear elution gradient employed was
formed from 0.05/99.95 (v/v) TFA/water to 0.05/19.95/80.0
(v/v/v) TFA/water/acetonitrile in 80min at a flow rate of
1mL/min. The effluent absorbance was monitored at 𝜆 =
214 nm and fractions of approximately 1mL were collected
automatically atminute intervals. Samples (100𝜇L) from each
chromatographic fraction were removed, lyophilized, and
stored at −20∘C prior to analysis for myoactivity using rat
smooth muscle bioassays.
2.3. Rat Smooth Muscle Bioassays. Male Wistar rats (250–
300 g) were euthanized by carbon dioxide asphyxiation fol-
lowed by cervical dislocation under appropriate UK animal
research lisences and following local institutional guidelines.
After removing the fur on the abdomen of rats, the body
cavity was opened and any visible fat was removed. The
exposed urinary bladder and the tail were carefully removed.
All dissected tissues were placed in ice-cold Kreb’s solu-
tion (118mM NaCl, 4.7mM KCl, 25mM NaHCO
3
, 1.15mM
NaH
2
PO
4
, 2.5mM CaCl
2
, 1.1 mM MgCl
2
, and 5.6mM glu-
cose) which was aerated with 95% O
2
/5% CO
2
gas mixture.
Strips of urinary bladder and rings of dissected tail artery
were prepared and tied with fine silk ligatures (0.2mm) at
each end. These preparations were attached to a fixed pin at
one end and to a transducer at the other end. Kreb’s solution
(at 37∘C) flowing through the organ baths at 2mL/min with
a constant bubbling of 95% O
2
/5% CO
2
maintained the
tissues in a viable state for >2 h. An equilibration period of
20min was used for each preparation after which 60mM
KCl was added to test the responsiveness of urinary bladder
muscle strips and 10−3M phenylephrine was added to test
the responsiveness of the tail artery rings and to cause
preconstriction. Following these tests, viable preparations
were used to screen prepared samples of reverse phase HPLC
fractions of Agalychnis callidryas skin secretion. Changes in
tension of smooth muscle preparations were detected by
pressure transducers connected to a PowerLab System (AD
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Instruments Pty Ltd.). Data were analyzed using GraphPad
Prism software anddata pointswere expressed asmean values
± standard errors, 𝑛 = 6 in each case.
2.4. Structural Characterization of the Novel Peptide. A single
reverse phase HPLC fraction was found to have a potent
relaxation effect on tail artery smooth muscle, a less potent
contractile action on urinary bladder smooth muscle strips
and amoderately potent antimicrobial effect. A sample of this
fraction was subjected to MALDI-TOF mass spectrometry
using a Perseptive BiosystemsVoyagerDEmass spectrometer
in positive detectionmodewith𝛼-cyano-4-hydroxycinnamic
acid as matrix. Subsequent to this analysis, the single major
peptide resolved was subjected to MS/MS fragmentation
sequencing using an LCQ Fleet electrospray ion-trap mass
spectrometer (Thermo-Fisher, San Jose, CA, USA).
2.5. Molecular Cloning of the Novel Peptide Biosynthetic
Precursor-Encoding cDNA. Five milligrams of lyophilized
skin secretion were dissolved in 1mL of cell lysis/mRNA
protection buffer that was supplied by Dynal Biotech, UK.
Polyadenylated mRNA was then isolated from this using
magnetic oligo-dT Dynabeads (Dynal Biotech, UK), as
per manufacturer’s instructions. The isolated polyadenylated
mRNA was then subjected to 5󸀠- and 3󸀠-rapid amplification
of cDNA ends (RACE) procedures to obtain full-length novel
peptide precursor nucleic acid sequence data using a SMART-
RACE kit (Clontech UK) likewise as per manufacturer’s
instructions. Briefly, the 3󸀠-RACE reactions employed a
nested universal (NUP) primer (supplied with the kit) and a
degenerate sense primer (SP: 5󸀠-GGIATGMGICCICCITGG-
3󸀠) (I = deoxyinosine, M = A/C) that was complementary to
the putative amino acid sequence, GMRPPW-, of the novel
peptide. The 3󸀠-RACE reactions were purified and cloned
using a pGEM-T vector system (Promega Corporation)
and sequenced using an ABI 3100 automated sequencer.
The sequence data obtained from the 3󸀠-RACE product
were used to design a specific antisense primer (ASP: 5󸀠-
CGGCACTATTACTGATAATTGTGCT-3󸀠) to a defined site
within the 3󸀠 nontranslated region of the novel peptide
precursor-encoding transcripts. 5󸀠-RACE was carried out
using these primers in conjunction with the NUP primer and
resultant products were purified, cloned, and sequenced.
2.6. Solid-Phase Peptide Synthesis. Once the unequivocal
primary structure of the novel peptide had been established,
it was chemically synthesized by solid-phase Fmoc chem-
istry using a PS3 automated solid-phase peptide synthesizer
(Protein Technologies, Inc., AZ, USA). Following cleavage
of the synthetic peptide from the resin and deprotection of
the side-chain protecting groups, the resultant material was
lyophilized and then purified by HPLC. The major product
was subjected toMALDI-TOFmass spectrometry to establish
both degree of purity and authenticity of structure.
2.7. Preliminary Pharmacological Characterization of the Syn-
thetic Novel Peptide on Rat Tail Artery and Urinary Bladder
Smooth Muscle. The synthetic peptide was initially prepared
as a stock in Kreb’s solution (118mM NaCl, 4.7mM KCl,
25mM NaHCO
3
, 1.15mM NaH
2
PO
4
, 2.5mM CaCl
2
, 1.1mM
MgCl
2
, and 5.6mM glucose) at a concentration of 10−3M.
Working concentrations of peptide, ranging from 10−3 to
1011M, were prepared prior to each experiment and were
applied to tissues (𝑛 = 6) progressively from low to high
concentrations. Data obtained from the PowerLab System
(AD Instruments Pty, Ltd.) were analyzed by Student’s t-test
through GraphPad Prism software to obtain the mean and
standard error of responses and using these datasets, dose-
response curves were constructed using a best-fit algorithm.
2.8. Determination of Minimal Inhibitory Concentrations
(MICs) of the Synthetic Novel Peptide for Model Microor-
ganisms. Minimal inhibitory concentrations (MICs) of the
synthetic peptide were assessed against three standard model
microorganisms: the Gram-positive bacterium Staphylococ-
cus aureus (S. aureus, NCTC 10788), the Gram-negative
bacterium Escherichia coli (E. coli, NCTC 10418) and the
pathogenic yeast Candida albicans (C. albicans, NCPF 1467).
The synthetic peptidewas initially dissolved in a small volume
of dimethylsulfoxide (DMSO) and made up to 1mL with
sterile Muellar-Hinton broth (MHB). Doubling dilutions of
this peptide stock solution peptide were made from 512–
1mg/L in sterile MHB and were incubated with microorgan-
ism cultures (106 colony forming units (CFU)/mL) in 96-well
microtiter cell culture plates for 18 h at 37∘C, in a humidified
atmosphere. MHB alone was used as a negative control and
eachmicroorganism inMHBwith no peptide addedwas used
as positive controls. After incubation, the growth of microor-
ganisms was determined by means of measuring optical
density (OD) at 𝜆 = 550 nm using an ELISA plate reader
(Biolise BioTek EL808). Minimal inhibitory concentrations
(MICs) were defined as the lowest concentration at which no
growth was detectable.
2.9. Hemolysis Assay. Peptide solutions in a range of con-
centrations were prepared as described in Section 2.8 but in
0.9% (w/v) aqueous NaCl solution, prior to performing the
hemolysis assay. A 2% suspension of washed horse red blood
cells in this solution was prepared from defibrinated horse
blood (TCS Biosciences Ltd., UK) and samples of this were
incubated at 37∘C for 120min, with a range of peptide con-
centrations similar to those employed for the antimicrobial
assays. Lysis of red cells was assessed by measurement of
the optical density of supernatants following centrifugation
at 𝜆 = 550 nm using an ELISA plate reader (Biolise BioTek
EL808). Negative controls employed consisted of a 2% (v/v)
red cell suspension alone and positive controls consisted of
a 2% (v/v) red cell suspension and an equal volume of saline
containing 2% (v/v) of the nonionic detergent, Triton X-100
(Sigma-Aldrich).
3. Results
3.1. Identification and Structural Characterization of the Novel
Peptide. Reverse phase HPLC fraction #33 of Agalychnis
callidryas skin secretion (Figure 1(a)) was found to contain
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Figure 1: Region of reverse phase HPLC chromatogram of Agalychnis callidryas skin secretion indicating the elution position/retention
time (arrow) of absorbance peak containing the peptide, AcT-2 (a). Expected singly and doubly charged b-ion and y-ions arising from
fragmentation of AcT-2 as predicted using the MS-Product program available through Protein Prospector online. Observed fragment ions
are indicated in bold type face and are underlined (b).
a myoactive peptide following preliminary smooth muscle
pharmacological screening and a sample of this fraction
was subjected to MALDI-TOF mass spectrometry which
indicated a relatively high degree of purity of a peptide
with an m/z (M+H)+ of 889.25. The doubly charged ion of
this peptide was subsequently identified following electro-
spray MS analysis and subjected to MS/MS fragmentation
sequencing (Figure 1(b)). This produced the tentative amino
acid sequence, GMRPPWF, based upon identification of b-
and y-ion series. The peptide was also deemed to be C-
terminally amidated. Bioinformatic analysis produced no hits
with any archived amphibian skin peptide but with two
synthetic antifungal peptides, named PAF-26 and combi-1
[12, 13] (Figure 2(a)). Of note was the presence of residues
3–8 of the novel myotropic peptide in a C-terminally-
located domain of a prophenin-2-like protein from the killer
whale (Orcinus orca) that contains a cathelicidin sequence
(accession no. XP004284013) (Figure 2(a)). However, the
origin and structural characteristics of the novel myotropic
peptide, an internal -PPW- sequence and C-terminal amida-
tion, indicated that it was a member of the amphibian skin
tryptophyllin family, subtype T-2, and thus it was named
Agalychnis callidryas tryptophyllin-2 (AcT-2) in accordance.
3.2. Molecular Cloning of AcT-2 Biosynthetic Precursor-
Encoding cDNA. A cDNA encoding the AcT-2 precursor
protein was successfully and repeatedly cloned using the
RACEPCR strategy employed.The sequencewas represented
in at least 30 clones after employing repetitive PCR and
cloning procedures. The complete nucleotide and translated
open-reading frame amino acid sequences of the cloned
AcT-2 biosynthetic precursor-encoding cDNA are shown in
Figure 2(b).The deduced open-reading frame consisted of 62
amino acid residues and shared a similar architecture with
the previously reported precursors of the tryptophyllins, PdT-
1 and PdT-2 from Pachymedusa dacnicolor skin secretion
(Chen et al. 2004, Wang et al. 2009) (Figure 2(c)). This
consisted of an N-terminal putative signal peptide, an acidic
amino acid residue-rich spacer peptide domain, a single copy
of a mature AcT-2 sequence, and a C-terminal processing
and amidation site (Figure 2(c)). As in the Pachymedusa
dacnicolor tryptophyllin precursors, the mature peptide was
flanked N-terminally by a double basic amino acid residue
propeptide convertase processing site - -RR-, cleavage of
which generated the N-terminus of mature AcT-2. The C-
terminal region of themature AcT-2 peptide was flanked by a
tripeptide sequence, -GKK, in commonwith the precursor of
PdT-2. The double basic amino acid motif, -KK, is removed
by propeptide convertase and the resulting C-terminal glycyl
(G) residue serves as an amide donor through the action of
amidating enzyme complex.
3.3. Smooth Muscle Activity of Synthetic AcT-2. Synthetic
AcT-2 was found to be active in smooth muscle preparations
from both rat tail artery and urinary bladder but in different
ways and at different potencies. In rat tail artery smoothmus-
cle preparations, AcT-2 caused a dose-dependent relaxation
with an EC
50
of 5.1 nM (Figure 3(a)). In contrast, the peptide
induced a dose-dependent contraction of urinary bladder
smooth muscle with an EC
50
of 9.3 𝜇M (Figure 3(b)).
3.4. Antimicrobial and Hemolytic Activity of AcT-2. AcT-2
was somewhat unexpectedly found to possess a broad spec-
trum of antimicrobial activity. MICs obtained with the three
model test organisms were as follows: S. aureus (256mg/L),
E. coli (512mg/L), and C. albicans (128mg/L) (Figures 4(a)–
4(c)). The order of sensitivity of the test organisms employed
was thus C. albicans > S. aureus > E. coli, which is a most
The Scientific World Journal 5
AcT-2 GM R PP W F
Prophenin-2-like R PP W F- ---
PAF26 R KK W F W
Combi-1 R RW W R F
(a)
M A S V K K S V F L V L F L G F I
1 ATGGCTTCGG TTAAGAAGTC TGTTTTCCTT GTCCTGTTCC TTGGATTCAT
TACCGAAGCC AATTCTTCAG ACAAAAGGAA CAGGACAAGG AACCTAAGTA
S I S F C D E E K R E D D E E G
51 TTCCATTTCC TTCTGTGATG AAGAGAAAAG AGAGGATGAC GAAGAAGGGA
AAGGTAAAGG AAGACACTAC TTCTCTTTTC TCTCCTACTG CTTCTTCCCT
N E R E E K R E I H E E G N Q E E
101 ATGAGAGAGA GGAAAAGAGA GAAATTCATG AAGAGGGAAA TCAAGAGGAG
TACTCTCTCT CCTTTTCTCT CTTTAAGTAC TTCTCCCTTT AGTTCTCCTC
R R G M R P P W F G K K
151 AGAAGAGGCA TGAGGCCTCC TTGGTTTGGA AAAAAGTAAC ATGTTATAAC
TCTTCTCCGT ACTCCGGAGG AACCAAACCT TTTTTCATTG TACAATATTG
201 CCTGAGGAGC ACAATTATCA GTAATAGTGC CGAAAACAGA ATAAAGCATC
GGACTCCTCG TGTTAATAGT CATTATCACG GCTTTTGTCT TATTTCGTAG
251 TGTAACTAAA AAAAAAAAAA AAAAAAAAAA AAAAAAAA
ACATTGATTT TTTTTTTTTT TTTTTTTTTT TTTTTTTT
∗
(b)
---------1--------- ---- --------2 ---------- - - - - -  --3 4--
AcT-2 M ASV KKS VFLVLFLGF ISISFC DEEKR EDDEEGNEREEKREIHEEG N Q E E R R GMRPPW F GK K
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(c)
Figure 2: Comparison of the primary structure of AcT-2 with those of similar peptides. PAF26 and combi-1 are synthetic antifungal peptides
isolated from combinatorial peptide libraries [12, 13]. Prophenin-2-like is a region of an antimicrobial polypeptide, cathelicidin, sequenced
from a genomic DNA template of the killer whale (Orcinus orca) (accession no. XP004284013). Conserved amino acid residues are shaded
black and consensus residues are shaded grey (a). Nucleotide and translated open-reading frame amino acid sequence of a cloned cDNA
encoding the biosynthetic precursor of AcT-2. The putative signal peptide is double-underlined, the mature peptide is single-underlined
and the stop codon is indicated by an asterisk (b). Alignments of complete open-reading frame amino acid sequences of AcT-2 precursor-
encoding cDNA with the two top hits obtained following BLAST analysis using the NCBI portal. PdT-1 and PdT-2 represent Pachymedusa
dacnicolor tryptophyllin-1 and -2, respectively. Conserved amino acids are shaded black and consensus amino acids are shaded grey. Gaps
have been inserted tomaximize alignments. (1) Putative signal peptide domain. (2) Acidic spacer peptide domain. (3)Mature peptide domain.
(4) C-terminal processing site (c).
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Figure 3: Dose-response curves obtained using synthetic AcT-2 on rat smooth muscle preparations. (a) Effect of the peptide on tail artery
smoothmuscle preparations expressed asmeans and standard errors (𝑛 = 6). EC
50
was found to be 5.1 nM. (b) Effect of the peptide on urinary
bladder smooth muscle preparations expressed as means and standard errors (𝑛 = 6). EC
50
was found to be 9.3 𝜇M.
unusual profile for previously reported typical amphibian
skin cationic, amphipathic, 𝛼-helical antimicrobial peptides.
Also worthy of note was the virtual lack of hemolytic activity
of AcT-2, even up to the highest concentration (512mg/L)
employed (Figure 4(d)).
4. Discussion
Central-American red-eyed leaf frogs (Agalychnis callidryas)
are probably the most universally recognized frogs in the
world having been used extensively by advertising agencies
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Figure 4:Minimal inhibitory concentration (MIC) curves obtained following incubation of synthetic AcT-2 with S. aureus (a), E. coli (b), and
C. albicans (c). The MIC value for each microorganism is indicated in respective panels by asterisks. (d) The hemolytic activity of synthetic
AcT-2. The arrow shows the highest concentration of peptide (512mg/L) which was the only concentration at which hemolysis was observed
(8.5%).
due to their strikingly beautiful colors. Although they are
one of the most widely available of the phyllomedusine leaf
frogs, studies on their defensive skin secretion peptides have
not been carried out with the same degree of focus that has
been given to many of their more obscure relatives [2, 14].
Red-eyed leaf frogs are most vividly colored with vibrant
lime-green dorsal surfaces, white ventral surfaces, cream and
cobalt-blue striped sides, and bright orange feet. Despite this,
frogs are difficult to see as they press themselves against
leaves and pull their limbs tightly towards their bodies, thus
becoming a green blob on the leaf surface. Their bright
coloration, however, is only present during the day when the
frogs are largely inactive, while, during the hours of darkness,
whenever the frogs are most active, their colors are much
drabber favouring shades of grey and brown [15].
The potent cocktails of defensive molecules present
in skin secretions effectively constitutes their front-line of
defense against predators [1, 2]. To date, several peptides
with a range of biological effects have been reported from
these skin secretions and these include both antimicrobial
and pharmacologically active peptides [1, 2, 16]. However,
AcT-2 described here represents the first skin secretion
tryptophyllin described from this species despite several
having been reported from Phyllomedusa species over the
past decades [2]. A recent report byWang et al. [9] described
a simple rational scheme to classify the rather structurally-
heterogenous group of amphibian skin peptides collectively
named tryptophyllins [9]. In this, peptideswere classified into
one of three groups, named T-1, T-2 and T-3 tryptophyllins,
based on some common structural features. On this basis,
AcT-2 shows the features of a type-2 (T-2) tryptophyllin, in
common with PdT-2 [9], as both possess an internal -PW-
sequence motif (Figure 2(c)). However, despite the presence
of this common internal structural feature, AcT-2 and PdT-
2 display radically different potencies in stimulating the
contraction of rat uterus smooth muscle (EC
50
values: AcT-2
= 9.3 𝜇M; PdT-2 = 4 nM), indicating that other features of the
primary structure influence their receptor interactions [9].
However, AcT-2 was found to possess a most potent arterial
smooth muscle relaxant effect (EC
50
= 5.1 nM)—an effect not
observed with PdT-2 [9]. The smooth muscle pharmacol-
ogy and molecular targets for these Type-2 tryptophyllins
in mammalian tissues obviously warrant further in-depth
investigation.
As demonstrated in this study, AcT-2 was unexpectedly
found to possess antimicrobial activity, albeit relatively low
potency, using three model test microorganisms with the
order of sensitivity being C. albicans > S. aureus > E. coli or
in other words, yeast > Gram-positive bacterium > Gram-
negative bacterium. Related to this observation was that
following database interrogation with the primary structure
of AcT-2, three peptides were found which displayed some
degree of structural identity (Figure 2(a)). Two of these,
named PAF26 and combi-1, were synthetic in nature and
were found through the screening of combinatorial peptide
libraries for antifungal activity [12, 13]. The third represented
a cathelicidin domain of a prophenin-2-like protein deduced
from a cloned cDNA of the killer whale (Orcinus orca)
(accession no. XP004284013). Interestingly, all three AcT-2-
like peptides were associated with antimicrobial functions,
with the former two being specifically against fungi.
While AcT-2 is of relatively low potency when compared
with many other amphibian skin antimicrobial peptides,
most if not all of the latter act through a mechanism of
microbial target cell membrane lysis and some are strongly
hemolytic [17–19]. To achieve this form of nonspecific
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antimicrobial action, such peptides are generallymuch longer
in amino acid chain length than AcT-2 [17, 19]. Thus,
AcT-2 may act upon a different and possibly intracellular
target rather than by direct lytic action on the cytoplasmic
membrane—a mode of action that has actually been pro-
posed for some “classical” antimicrobial peptides as well [17,
19]. In support of this proposal to some degree is the lack of
hemolytic activity of AcT-2 observed following its incubation
with horse erythrocytes (Figure 4(d)).
In conclusion, the novel amphibian skin tryptophyllin,
named AcT-2, described here, has been demonstrated to
have both selective mammalian smooth muscle myotropic
effects and antimicrobial activity—findings which add to
our increasing knowledge of the biological effects of this
enigmatic family of amphibian skin peptides.
Thenucleotide sequence ofAcT-2, from the skin secretion
of Agalychnis callidryas, has been deposited in the EMBL
Nucleotide Sequence Database under the accession code
HG710094.
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